Dunxin Financial Holdings Limited Reports Financial Results for the First Six Months of 2022
Dunxin Financial Holdings Limited (NYSE American: DXF) reported its unaudited financial results for the first six months of 2022, revealing a net profit of RMB60.2 million (US$9.3 million), a 14.9% decrease from the same period in 2021. Total interest income fell by 30% to RMB57.8 million (US$8.9 million), while net interest income dropped 34.5% to RMB47.7 million (US$7.3 million). Loans receivable increased by 13.2% to RMB628.6 million (US$93.8 million), yet the company continues to face liquidity challenges and overdue loan obligations amidst ongoing legal proceedings related to its financial difficulties.
- Loans receivable, net of credit impairment losses increased by 13.2% to RMB628.6 million (US$93.8 million).
- Credit impairment losses were reversed to RMB16.4 million during the first half of 2022.
- Total interest income decreased by 30% to RMB57.8 million (US$8.9 million).
- Net interest income dropped 34.5% to RMB47.7 million (US$7.3 million).
- Net profit fell by 14.9% to RMB60.2 million (US$9.3 million).
- Earnings per ADS decreased to US$0.35 from US$0.52 in the prior year.
- The company faces liquidity issues, with most cash deposits frozen due to legal proceedings.
WUHAN, China, Sept. 28, 2022 /PRNewswire/ -- Dunxin Financial Holdings Limited ("Dunxin" or the "Company") (NYSE American: DXF), a licensed microfinance lender servicing individuals and small and medium enterprises ("SMEs") in Hubei Province, China, today announced its unaudited financial results for the first six months of 2022. The unaudited consolidated financial statements and other financial information included in this press release have been stated in Renminbi ("RMB") unless otherwise indicated.
First Six Months 2022 Highlights
- Total outstanding principal balance of loans dropped to RMB753.6 million (US
$112.5 million ) as of June 30, 2022, representing a decrease of0.1% from RMB754.4 million as of December 31, 2021. - Loans receivable, net of credit impairment losses of RMB581.5 million (US
$86.8 million ), was RMB628.6 million (US$93.8 million ) as of June 30, 2022, representing an increase of13.2% from RMB555.1 million as of December 31, 2021. - Total interest income was RMB57.8 million (US
$8.9 million ) in the first six months of 2022, representing a decrease of30.0% from RMB82.6 million in the same period of the prior year. - Net interest income was RMB47.7 million (US
$7.3 million ) in the first six months of 2022, representing a decrease of34.5% from RMB72.8 million in the same period of the prior year. - Net profit was RMB60.2 million (US
$9.3 million ) in the first six months of 2022, representing a decrease of14.9% from RMB70.7 million in the same period of the prior year. - Earnings per American Depositary Share ("ADS") was US
$0.35 in the first six months of 2022 compared to US$0.52 in the same period of the prior year.
First Six Months 2022 Financial Results
Interest Income on Loans
Interest income on loans primarily consists of the accrued interest of Stage 3 credit-impaired loans. Accrued interest is the present value of the estimated future cash flows of credit-impaired loans expected to be recovered, discounted at the loan's original effective interest rate. Interest income on loans for the first six months of 2022 decreased by
Interest Expense
Interest expenses on loans increased to RMB10.0 million (US
Net Interest Income
Net interest income for the first six months of 2022 was RMB47.7 million (US
Credit Impairment Losses
The Company maintains the allowance for loan losses, as presented in the financial statements, at a level it considers to be reasonable by management to absorb probable losses inherent in the loan portfolio as of each balance sheet date. The management evaluates the adequacy of the allowance for loan losses on a regular basis or more often as necessary. The allowance is based on the past loan loss history, known and inherent risks in the portfolio, adverse situations that may affect the borrower's ability to repay, the estimated value of any underlying collateral, composition of the loan portfolio, current economic conditions and other relevant factors. This evaluation is inherently subjective as it requires material estimates that may be susceptible to significant revision as more information becomes available.
The Company reversed the credit impairment losses to RMB16.4 million for the first six months of 2022. The increase was primarily attributable to the revaluation of the present value of interest receivable and estimated recovery date during the first six months of 2022. Therefore, the Company reversed the over-provision of credit impairment losses recognised in the prior period. Although the economic and business environment for SMEs remained challenging and some of the Company's loan customers were experiencing financial difficulty, the Company believed that the recoverability of loan was much more optimistic due to effective government controls of the epidemic and therefore no additional credit impairment loss was provided for the first six months of 2022. The Company assessed credit loss allowance on these credit-impaired loans based on an assessment of the recoverable cash flows under a range of scenarios, including the realization of any collateral held where appropriate. The loss provisions held represent the difference between the present value of the cash flows expected to be recovered, discounted at the instrument's original effective interest rate, and the gross carrying value of the instrument prior to any credit impairment.
Operation Expenses
Operating expenses consisted solely of general and administrative expenses, which increased from RMB2.5 million for the first six months of 2021 to RMB3.9 million (US
Net Profit and Earnings per ADS
As a result of the foregoing, net profit was RMB60.2 million (US
Earnings per ADS for the first six months of 2022 was US
Statements of Financial Position
As of June 30, 2022, the Company had cash and restricted cash of RMB197,000 (US
Loans receivable, net of credit impairment losses of RMB581.5 million (US
As of December 31, 2021 and June 30, 2022, loans payable to third parties, related parties and shareholders, amounting to RMB161.6 million (US
Statements of Cash Flows
Net cash used by operating activities for the first six months of 2022 was RMB29,000 compared to RMB1,000 net cash used by operating activities in the same period of the prior year and the Company has very limited liquidity available to fulfil its obligations for the first six months of 2022.
COVID-19
Since December 2019, COVID-19 has become widespread in China and many other countries. The pandemic has resulted in mandatory quarantines, travel restrictions, and the temporary closure of stores and facilities in China and other parts of the world for the past few months, and certain areas remain subject to such heightened measures. In March 2020, the World Health Organization declared the COVID-19 a pandemic. As a company headquartered in Wuhan, the epicenter of the pandemic in 2020, with substantially all operating activities, revenues and workforce in Wuhan, our results of operations and financial outlook were materially and adversely affected by the outbreak of COVID-19 including, but not limited to, delays in loan payments and collection of accounts receivable, and decrease in business development.
The outbreak of COVID-19 and the resulting widespread health crisis has also adversely affected economies and financial markets globally, which could result in an economic downturn that could affect our operations and future revenue and operating results.
While we have undertaken a series of mitigating initiates and efforts to alleviate impact of COVID -19 on our business, including but not limited to, proactively working with our customers to collect payments and renegotiating of the repayment schedule with our creditors as well as carefully controlling our administrative expenses. There is no assurance that these initiatives and efforts will successfully mitigate the impact. In addition, our business operations could be disrupted if any of our employees is suspected of having or has COVID-19 or any other epidemic disease, since it could require our employees to be quarantined and/or our offices to be closed for disinfection or other remedial measures.
Although the COVID-19 pandemic appears to be contained in China, waves of new infections still occur from time to time. While vaccines for COVID-19 are being, and have been developed, there is no guarantee that any such vaccine will be effective, work as expected or be made available or will be accepted on a significant scale and in a timely manner. Furthermore, variations of virus were recently found on confirmed cases outside China. The outlook for COVID-19 remains fluid and its long-term implications on our business and results of operations are uncertain. The extent to which this outbreak impacts our results of operations will depend on future developments, which are highly uncertain and unpredictable, including new information that may emerge concerning the severity of this outbreak and future actions, if any, to contain this outbreak or treat its impact, among others. We are closely monitoring the pandemic and its impact on us.
Safe Harbor Statement
This news release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates," "target," "going forward," "outlook" and similar statements. Such statements are based upon management's current expectations and current market and operating conditions, and relate to events that involve known or unknown risks, uncertainties and other factors, all of which are difficult to predict and many of which are beyond the Company's control, which may cause the Company's actual results, performance or achievements to differ materially from those in the forward-looking statements. Further information regarding these and other risks, uncertainties or factors is included in the Company's filings with the U.S. Securities and Exchange Commission. The Company does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under law.
Exchange Rate Information
The United States dollar (US$) amounts disclosed in this press release are presented solely for the convenience of the reader. Translations of amounts from Renminbi ("RMB") into United States dollars for the convenience of the reader were calculated at the certified exchange rate of US
About Dunxin Financial Holdings Limited
Dunxin is a licensed microfinance lender in Hubei Province, China. The Company has been granted a microfinance license by the Financial Affairs Office of the Hubei Provincial People's Government to provide loans to individuals and SMEs. The Company was awarded the "Vice President Unit" of China Micro-credit Companies Association under the China Banking Regulatory Commission in January 2017 and the "President Unit" of Hubei Micro-credit Company Association in December 2017. In 2016, we were recognized as a "National Excellent Microfinance Company" by China Micro-credit Companies Association. We have been named one of the "Top 100 Most Competitive Microfinance Companies in China" by China Microfinance Institution Association for four consecutive years since 2013, an "AA- Credit Rating Enterprise" by China Credit Management Co., Ltd in August 2017, and a "Top 10 Private Enterprises in Wuchang District, Wuhan City" by the People's Government of Wuchang District in July 2017. The Company has professional credit business experience in the microfinance industry in China. For more information, please visit the Company's website at http://hbctxed.com.
DUNXIN FINANCIAL HOLDINGS LIMITED | ||||||||||||
UNAUDITED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME | ||||||||||||
(Expressed in Thousands of Chinese Renminbi Yuan, except per share and per ADS amounts) | ||||||||||||
For the six months ended June 30 | ||||||||||||
2021 RMB | 2022 RMB | 2022 US$ | ||||||||||
Interest income on loans | 82,562 | 57,844 | 8,902 | |||||||||
Interest expense: | ||||||||||||
Interest expenses on loans | (9,473) | (9,988) | (1,537) | |||||||||
Business related taxes and surcharges | (304) | (203) | (31) | |||||||||
Total interest expense | (9,777) | (10,191) | (1,568) | |||||||||
Net interest income | 72,785 | 47,653 | 7,334 | |||||||||
Reversal of credit impairment losses | 416 | 16,382 | 2,521 | |||||||||
Net interest income after credit impairment losses | 73,201 | 64,035 | 9,855 | |||||||||
Operating costs and expenses | ||||||||||||
General and administrative | (2,502) | (3,866) | (595) | |||||||||
Total operating costs and expenses | (2,502) | (3,866) | (595) | |||||||||
Profit before income taxes | 70,699 | 60,169 | 9,260 | |||||||||
Income tax expense | - | - | - | |||||||||
Net profit | 70,699 | 60,169 | 9,260 | |||||||||
Other comprehensive income for the period: | ||||||||||||
Exchange differences on translation of financial | (10) | (170) | (26) | |||||||||
Total comprehensive income for the period | 70,689 | 59,999 | 9,234 | |||||||||
Net profit attributable to: | ||||||||||||
Equity holders of the Company | 56,558 | 48,136 | 7,408 | |||||||||
Non-controlling interests | 14,141 | 12,033 | 1,852 | |||||||||
Net profit | 70,699 | 60,169 | 9,260 | |||||||||
Total comprehensive income attributable to: | ||||||||||||
Equity holders of the Company | 56,551 | 47,999 | 7,387 | |||||||||
Non-controlling interests | 14,138 | 12,000 | 1,847 | |||||||||
Total comprehensive income | 70,689 | 59,999 | 9,234 | |||||||||
Earnings per share - basic and diluted (in RMB) | 0.07 | 0.05 | ||||||||||
Earnings per ADS - basic and diluted (in US$) | 0.52 | 0.35 | ||||||||||
Weighted average shares outstanding in the period | 1,002,201 | 1,002,201 | ||||||||||
Weighted average ADS outstanding in the period | 20,879 | 20,879 | ||||||||||
One ADS represents 48 ordinary shares. |
DUNXIN FINANCIAL HOLDINGS LIMITED | ||||||||||||
CONSOLIDATED STATEMENTS OF FINANCIAL POSITION | ||||||||||||
(Expressed in Thousands of Chinese Renminbi Yuan) | ||||||||||||
As of | ||||||||||||
December 31, | June 30, | June 30, | ||||||||||
2021 | 2022 | 2022 | ||||||||||
RMB | RMB | US$ | ||||||||||
Unaudited | Unaudited | |||||||||||
Assets | ||||||||||||
Current assets | ||||||||||||
Cash and restricted cash | 396 | 197 | 29 | |||||||||
Loans receivable, net of credit impairment | 555,133 | 628,608 | 93,826 | |||||||||
Prepaid expenses and others | 848 | 1,006 | 151 | |||||||||
Total current assets | 556,377 | 629,811 | 94,006 | |||||||||
Non-current assets | ||||||||||||
Property and equipment, net | 42,180 | 40,703 | 6,075 | |||||||||
Intangible asset | 5 | 5 | 1 | |||||||||
Total non-current assets | 42,185 | 40,708 | 6,076 | |||||||||
Total assets | 598,562 | 670,519 | 100,082 | |||||||||
Liabilities | ||||||||||||
Loans payable | 161,569 | 161,569 | 24,116 | |||||||||
Salary and benefit payable | 9,872 | 10,940 | 1,633 | |||||||||
Income taxes payable | 32,477 | 32,477 | 4,848 | |||||||||
Interest payable | 54,685 | 63,700 | 9,508 | |||||||||
Other payable | 21,656 | 23,531 | 3,512 | |||||||||
Total current liabilities | 280,259 | 292,217 | 43,617 | |||||||||
Shareholders' equity | ||||||||||||
Capital and reserve attributable to equity | ||||||||||||
Share capital | 326 | 326 | 49 | |||||||||
Additional paid-in capital | 383,174 | 383,174 | 57,193 | |||||||||
Statutory reserve | 18,706 | 18,706 | 2,792 | |||||||||
General risk reserve | 9,180 | 9,180 | 1,370 | |||||||||
Foreign currency translation reserve | 30 | (106) | (16) | |||||||||
Accumulated losses | (156,774) | (108,639) | (16,216) | |||||||||
Non-controlling interests in equity | 63,661 | 75,661 | 11,293 | |||||||||
Total shareholders' equity | 318,303 | 378,302 | 56,465 | |||||||||
Total equity and liabilities | 598,562 | 670,519 | 100,082 |
DUNXIN FINANCIAL HOLDINGS LIMITED | |||||||||||||||
UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS | |||||||||||||||
(Expressed in Thousands of Chinese Renminbi Yuan) | |||||||||||||||
For the six months ended June 30, | |||||||||||||||
2021 | 2022 | 2022 | |||||||||||||
RMB | RMB | US$ | |||||||||||||
Cash flows from operating activities: | |||||||||||||||
Profit before income taxes | 70,699 | 60,169 | 9,260 | ||||||||||||
Adjustments for: | |||||||||||||||
Depreciation of property and equipment | 1,489 | 1,477 | 227 | ||||||||||||
Amortization of intangible asset | * | * | * | ||||||||||||
Reversal of credit impairment losses | (416) | (16,382) | (2,521) | ||||||||||||
Operating profit before working capital changes | 71,772 | 45,264 | 6,966 | ||||||||||||
Loans receivable | (74,262) | (57,093) | (8,786) | ||||||||||||
Prepaid expenses and others | (32) | (158) | (24) | ||||||||||||
Salary and benefit payable | 847 | 1,068 | 164 | ||||||||||||
Loans payable | (10,000) | - | - | ||||||||||||
Interest payable | 9,472 | 9,015 | 1,387 | ||||||||||||
Other payable | 2,202 | 1,875 | 288 | ||||||||||||
Cash used in operating activities | (1) | (29) | (5) | ||||||||||||
Income tax paid | - | - | - | ||||||||||||
Net cash used in operating activities | (1) | (29) | (5) | ||||||||||||
Net decrease in cash and restricted cash | (1) | (29) | (5) | ||||||||||||
Cash and restricted cash at beginning of the | 97 | 396 | 60 | ||||||||||||
Exchange losses on cash and restricted cash | - | (170) | (26) | ||||||||||||
Cash and restricted cash at end of the period | 96 | 197 | 29 | ||||||||||||
* Less than 1,000. |
View original content:https://www.prnewswire.com/news-releases/dunxin-financial-holdings-limited-reports-financial-results-for-the-first-six-months-of-2022-301635341.html
SOURCE Dunxin Financial Holding Limited
FAQ
What were Dunxin Financial Holdings' earnings results for the first half of 2022?
How much did total interest income decrease for Dunxin in H1 2022?
What is the current status of Dunxin's loans receivable?
What challenges does Dunxin Financial face regarding liquidity?